KLRC2 and non-Hodgkin lymphoma: The finding that NKG2A+NKG2C+, rather than NKG2A+NKG2C- NK cells prevented the in vitro EBV+ lymphoma cell dissemination, prompted us to further analyse the role of NKG2C+ NK cells in the prevention of EBV+HL and EBV+nHL.